Can BioNTech Revolutionize Cancer Treatment Amid Financial Turmoil?
BioNTech faces significant financial challenges with profits plummeting and a substantial predicted net loss as the company shifts focus from vaccines to pioneering mRNA-based cancer therapies. The biotech firm is…